Device Trial Radar · NCT05946603
IS-002 Phase 2 Prostate Cancer Study
Last checked: Nov 19, 2026Latest source record: Sep 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
59
Actual
Start
Jun 16, 2023
Primary completion
May 21, 2024
Study completion May 23, 2025
Sponsor
- Lead sponsor
- Intuitive SurgicalPublic (ISRG)
- Sponsor type
- Industry
- First posted
- Jul 14, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- Male only, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Phase 2 randomized controlled multi-center study of IS-002, in conjunction with near-infrared (NIR) fluorescence imaging, for identification of prostate cancer during robotic-assisted radical prostatectomy (RARP) with (extended) pelvic lymph node dissection ((e)PLND) using the da Vinci® X/Xi Surgical System with Firefly® Fluorescence Imaging.
Conditions
- Prostate Cancer
Interventions
Administration of IS-002Drug
Intravenous administration of IS-002 approximately 24 hours prior to surgery
Firefly fluorescent imagingDevice
Near-infrared fluorescence imaging using Firefly technology will allow fluorescence imaging of IS-002
robotic-assisted laparoscopic prostatectomy with pelvic lymph node dissectionProcedure
Subject will undergo robotic-assisted laparoscopic prostatectomy with pelvic lymph node dissection
Primary outcomes
What the sponsor says the trial is designed to measure.
- The proportion of subjects with ≥1 positive surgical margins (PSMs) on final histopathologic assessment in the Intervention arm and the Control arm.Time frame: Within 3 months post-surgery
- The mean number of positive surgical margins (PSMs) on final histopathologic assessment in the Intervention arm and the Control arm.Time frame: Within 3 months post-surgery
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
UCSF
San Francisco, California
Johns Hopkins
Baltimore, Maryland
Mayo Clinic
Rochester, Minnesota
1 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.